Fidler MC, Sanchez M, Raether B, et al
Methods On October 2024, a systematic search was conducted on ClinicalTrials.gov to identify relevant studies exploring the use of GLP-1 for managing GDM
To remedy this, the FDA will need to issue new regulations to manage the drug shortage list or Congress will need to provide it more explicit authority, they noted
While Ozempic and Wegovy contain semaglutide, Mounjaro contains tirzepatide and works on both GLP-1 and GIP receptors
For this reason, it serves as a valuable tool for studying cellular fat clearance and metabolic rate acceleration
Unfortunately, theres no one-size-fits-all answer here